Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

How friendly bacteria avoids immune attack to live happily in the gut

02.09.2008
For a long time scientists have been puzzled by the fact that the immune system in the gut is capable of fighting toxic bacterial infection while staying, at the same time, tolerant to its resident “friendly” bacteria.

But an article now published in the journal Cell Host & Microbe1 is starting to open the door to this mystery by revealing how a recently discovered gene - pims – is activated by the gut immune response against friendly bacteria to rapidly suppress it, effectively creating tolerance to the gut microbiota.

In the same way pims is also shown to control the magnitude of immune responses against toxic bacteria by suppressing immuno-reactivity when a certain activation threshold is achieved, assuring, in this way, that the response stays restricted to the infection site and is proportional to the extent of the infection. These results suggest that the balance tolerance/immuno-reaction in the gut is achieved through self-regulatory cycles where suppression by negative regulators, such as pims, is triggered as soon as a specific threshold of immuno activation is reached.

This work has implications in the understanding of diseases in which the normal gut immune response is disrupted - such as Crohn's disease and ulcerative colitis – but, potentially, also in oral tolerance. In fact, oral tolerance vaccines - in which the molecule we want immuno-tolerated is ingested - have been tentatively used for the treatment of several autoimmune diseases (where the immune system abnormally attacks parts of the body) with mixed results and the new research, by elucidating the players in gut immuno-tolerance, might help to understand why.

Multicellular animals live peacefully in close contact with a multitude of microorganisms that inhabit their bodies. Humans, for example, have more microorganisms within the body than cells, with just the intestine containing up to 100 trillion microbes, a number about 10 times greater that all our cells. Still, although we remain fully immune competent - so capable of responding to infection by pathogenic microorganisms - we do not react against these “friendly” bacteria. But how do these two opposite immune responses against bacteria so similar exist simultaneously?

In order to understand better this phenomenon Nouara Lhocine, Paulo S. Ribeiro, Francois Leulier and colleagues working in France, London, Switzerland and Portugal used Drosophila (fruit fly) – a common animal model to study human gene functions due to the large numbers of genes shared by the two species - to investigate the possibility that a recently discovered gene – pims – could be involved in this coexistence of tolerance and immuno-reactivity.

In fact, in the Drosophila gut, one of the main responses against bacterial infection is the Imd pathway. The activation of this immune pathway is triggered by peptidoglycans – sugars found on the bacterial wall – and results in the activation of a molecule called Relish. Once activated, Relish induces the expression of several antimicrobial genes to neutralize the invading pathogens. “Friendly” bacteria, on the other hand, despite containing peptidoglycans in their wall exist peacefully inside Drosophila’s gut. The new found gene– pims – was shown to be expressed during bacterial infection in the gut while its inhibition apparently disrupted the Imd pathway suggesting a role in the regulation of this pathway.

Lhocine, Ribeiro, Leulier and colleagues started by analysing pims expression in Drosophila to find it mainly expressed in the gut where it depends on the existence of “friendly” bacteria and activated Relish. These results further suggested – since a basal level of immune response is necessary for pims expression - that this gene acted on the immune response and, specifically, in the gut.

The next step was to analyse what happened to this gut immune response in animals lacking pims. And it was found that, not only these animals showed an immune response against “friendly” bacteria, but also that, during toxic bacterial infection the immune response abnormally spread out of the site of infection risking body injury. These results reveal pims as a negative regulator of the immune response (Imd pathway) granting tolerance to “friendly” gut bacteria, but also assuring that immune responses against infection are contained to the site of infection.

Although the exact mechanism of pims is not fully understood, Lhocine, Ribeiro, Leulier and colleagues were able to show that the peptide produced by pims binds a peptidoglycan receptor, part of the Imd pathway, called PGRP-LCx, . As PGRP-LCx recognition of peptidoglycans activates Imd and ultimately Relish, the outcome of the interaction with Pims is lack of availability to peptidoglycans and consequently suppression of the (Imd) immune response. Results from microscopic observation and separation of the cell’s soluble and insoluble components suggested, however, that PIMS acted, not by destroying PGRP-LCx but by misplacing it, away from its usual localisation – the plasma membrane – resulting in an incapability of the immune system to see peptidoglycans and consequently of getting activated.

Lhocine, Ribeiro, Leulier and colleagues’ results suggest a model where pims is a negative immuno-regulator triggered when specific Imd activation thresholds are reached, after which the immune response is suppressed. It is the existence of this immuno-reactivity threshold that allows the simultaneous existence of tolerance to the gut microorganisms while maintaining immuno-reactivity against infection.. Since peptidoglycans are widely present in bacteria the next question would be to find if the regulatory system here described applies to other host-microorganisms interactions, including those involving humans.

Piece by Catarina Amorim ( catarina.amorim at linacre.ox.ac.uk)

Contacts for the authors of the original paper
Nouara Lhocine
Paulo S. Ribeiro - paulo.ribeiro@icr.ac.uk
Francois Leulier - leulier@cgm.cnrs-gif.fr

Catarina Amorim | alfa
Further information:
http://www.estatisticas.gpeari.mctes.pt
http://www.cellhostandmicrobe.com/content/article/abstract?uid=PIIS1931312808002229

More articles from Life Sciences:

nachricht Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute

nachricht Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>